M. Wiltshire, A. Meli, M. Schott
Jun 1, 2016
Citations
1
Influential Citations
13
Citations
Quality indicators
Journal
Transfusion Medicine
Abstract
The pathogen inactivation (PI) INTERCEPT Blood System for Red Blood Cells utilises amustaline (S‐303) to inactivate a broad range of pathogens in red cell concentrates (RCC). The aim of this study was to investigate the effect on red cell quality of INTERCEPT treatment with and without prion reduction.